The CDC is looking into rare reports of myocarditis in teens who received a COVID-19 vaccine; reduced air pollution during lockdowns prevented premature deaths; new COVID-19 cases in the United States fall to a 1-year low.
The CDC is investigating several dozen cases of possible myocarditis reported in teenagers and young adults after they received a COVID-19 vaccination, The New York Times reports. However, it is currently unknown if the vaccine causes the condition; it's possible they may be unrelated to vaccination. The CDC’s statement only noted “relatively few” cases have been reported. Myocarditis is defined as inflammation of the heart muscle and can occur after certain infections. Guidance on the agency’s website urges providers to be alert for unusual heart symptoms among patients in this age range who received a vaccine.
Throughout 2020, the sharp decrease in human-made emissions resulting from numerous COVID-19 lockdowns prevented approximately 32,000 premature mortalities, according to new research published in Science Advances. Researchers used global satellite observations and ground measurements across 36 countries in Europe, North America, and East Asia to reach the estimate. Of the 32,000 deaths prevented, roughly 21,000 were recorded in China alone. The investigation focused on rates of nitrogen dioxide but did not find corresponding reductions of particulate matter 2.5 and ozone globally.
Levels of US COVID-19 cases hit their lowest point since June of 2020 according to data from Johns Hopkins University, CNBC reports. Currently, around 49% of the US population has received at least 1 dose of a COVID-19 vaccine, 39% are fully vaccinated, and among adults 18 years and older, 61% are partially vaccinated. As of May 23, 2021, the 7-day average of new infections was reported at 26,000. The news comes after the CDC issued revised mask guidance earlier in May, stating fully vaccinated individuals can shed their masks in most indoor and all outdoor settings.
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Coexistence of HIV, Hemophilia May Lead to Increased Presence of Coronary Artery Stenosis
May 8th 2024In patients living with HIV, the cardiovascular risk factors that come with infection may lead to an increased prevalence of coronary artery stenosis, especially in those who also have hemophilia.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More